Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K
Asthma I: Introduction01:28

Asthma I: Introduction

112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.

The New England journal of medicine·2016
Same author

Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma.

The pharmacogenomics journal·2015
Same author

Impact of a novel nutritional formula on asthma control and biomarkers of allergic airway inflammation in children.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010
Same author

Predicting worsening asthma control following the common cold.

The European respiratory journal·2008
Same author

A new perspective on concepts of asthma severity and control.

The European respiratory journal·2008
Same author

Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2002

Related Experiment Video

Updated: May 3, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 14, 2010

22.3K

The changing faces of asthma.

S J Szefler1

  • 1Division of Clinical Pharmacology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206, USA.

The Journal of Allergy and Clinical Immunology
|September 13, 2000
PubMed
Summary

Asthma management has evolved from symptom relief to addressing chronic airway inflammation with anti-inflammatory drugs. Understanding disease progression is key to selecting effective, long-term asthma treatments.

Area of Science:

  • Pulmonology
  • Immunology
  • Pharmacology

Background:

  • Asthma understanding has shifted significantly over two decades.
  • Current view: Asthma is a chronic airway inflammatory disease.
  • Management now includes anti-inflammatory maintenance therapy and action plans.

Purpose of the Study:

  • Review the evolution of asthma pathogenesis understanding.
  • Analyze the impact of new knowledge on medication selection.
  • Discuss methods for evaluating long-term medication effects on asthma outcomes.

Main Methods:

  • Literature review on asthma pathogenesis and management.
  • Analysis of current treatment paradigms.
  • Exploration of outcome assessment strategies for asthma medications.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 5, 2010

34.4K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K

Related Experiment Videos

Last Updated: May 3, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 14, 2010

22.3K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 5, 2010

34.4K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.2K

Main Results:

  • Asthma is recognized as chronic airway inflammation.
  • Shift from as-needed bronchodilators to maintenance anti-inflammatory therapy.
  • Emphasis on disease-modifying drugs and long-term outcome markers.

Conclusions:

  • Asthma management requires a comprehensive understanding of its inflammatory nature.
  • Medication selection should consider disease modification and long-term outcomes.
  • Continuous reevaluation of information will enhance asthma care strategies.